Wolverine Trading’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,800
Closed -$327K 6307
2021
Q4
$327K Buy
5,800
+800
+16% +$40.5K ﹤0.01% 4034
2021
Q3
$242K Buy
+5,000
New +$255K ﹤0.01% 5042
2020
Q3
Sell
-16,400
Closed -$461K 5058
2020
Q2
$461K Buy
+16,400
New +$462K ﹤0.01% 2822
2020
Q1
Sell
-9,200
Closed -$291K 5176
2019
Q4
$291K Buy
+9,200
New +$257K ﹤0.01% 3631
2018
Q1
Sell
-13,200
Closed -$291K 5732
2017
Q4
$291K Buy
+13,200
New +$287K ﹤0.01% 3675

Other funds holding RXL

Wolverine Trading's RXL Position: Q4 2020 in Review

Wolverine Trading sold out of ProShares Ultra Health Care (RXL) in Q4 2020, closing a stake of 13,884 shares — an estimated $438K sold.

Wolverine Trading first reported a position in RXL in Q3 2017 and held it in 6 quarters. The position peaked at $438K in Q3 2020. 17 funds tracked by Wall St. Rank hold RXL as of Q4 2020.

  • Wolverine Trading reported no remaining ProShares Ultra Health Care position as of Q4 2020 after selling out during the quarter.
  • Wolverine Trading sold 13,884 ProShares Ultra Health Care shares in Q4 2020, an estimated $438K.
  • Wolverine Trading first reported a position in ProShares Ultra Health Care in Q3 2017 and held it in 6 quarters.
  • Wolverine Trading's ProShares Ultra Health Care position peaked at $438K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2020.

Based on Wolverine Trading's 13F filing for Q4 2020, filed 12 Feb 2021.